Creator: Dr. M. Sree Mohana Preetha
Keywords: Bivasave (250mg), Bivalirudin brands in India, Bivalirudin, Bivasave (250mg) price, AHPL

Bivasave (250mg) (Bivalirudin) Drug Price and Information

Information Checked by - Dr. M. Sree Mohana Preetha, Pharm D

Further Checked by - Dr. M. Janani Priya, Pharm D

Last Updated on August 08, 2019

Bivalirudin (Bivasave (250mg)) is an anticoagulant (thrombin inhibitor), prescribed for preventing blood clots in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty ((PTCA) procedure to open blocked arteries).

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.

Bivasave (250mg) - AHPL

Bivasave (250mg) Injection

Generic : Bivalirudin

₹ 8599.5

250mg

Price Updated on August 08, 2019

Update the Drug Info ADD Drug Info

Substitute/Alternative Medication to Bivasave (250mg)

Bivasave | Bivastat (250mg)

More ....

When is Bivasave (250mg) prescribed?

It is prescribed for -

⇨ Chest Pain

Disclaimer :

Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:

Difference in GST/local taxes
Change in price by the company
Updation of price information may not have happened at the right time

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does not intend to replace professional medical opinion in any manner whatsoever. Please also be aware that Medindia does not buy or sell medication.

Published on Jul 14, 2016
Last Updated on August 08, 2019